Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and two have given a strong buy rating to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $2.50.
A number of research analysts have commented on CRLBF shares. Ventum Cap Mkts raised Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Roth Capital upgraded Cresco Labs from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 9th. Needham & Company LLC reiterated a “hold” rating on shares of Cresco Labs in a research note on Monday, August 12th. Finally, Wedbush increased their target price on shares of Cresco Labs from $2.50 to $3.00 and gave the stock an “outperform” rating in a report on Thursday, May 16th.
Read Our Latest Stock Analysis on CRLBF
Cresco Labs Trading Up 5.0 %
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.15). The company had revenue of $184.36 million during the quarter, compared to analyst estimates of $184.26 million. Cresco Labs had a negative net margin of 23.07% and a negative return on equity of 17.03%. As a group, research analysts expect that Cresco Labs will post -0.13 EPS for the current fiscal year.
Cresco Labs Company Profile
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Stories
- Five stocks we like better than Cresco Labs
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Small Cap Stocks That Insiders Are Buying
- Canada Bond Market Holiday: How to Invest and Trade
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- What Are Trending Stocks? Trending Stocks Explained
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.